HLVX

1.99

1.53% 0.03

Handel nachbörslich: 1.93 -0.06 -3.02%

Hillevax Inc (HLVX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$1.96

Offen:

$1.98

24-Stunden-Volumen:

101.26K

Relative Volume:

0.44

Marktkapitalisierung:

$99.78M

Einnahmen:

Nettoeinkommen (Verlust:

$-123.57M

KGV:

-0.6546

EPS:

-3.04

Netto-Cashflow:

$-97.53M

1W Leistung:

+6.42%

1M Leistung:

+5.85%

6M Leistung:

-1.00%

1J Leistung:

-85.53%

1-Tages-Spanne:

$1.93

$2.02

1-Wochen-Bereich:

$1.86

$2.02

52-Wochen-Spanne:

$1.34

$15.60

Hillevax Inc Stock (HLVX) Company Profile

Firmenname

Hillevax Inc

Sektor

Healthcare (1171)

Branche

Biotechnology (667)

Telefon

(617) 213-5054

Adresse

321 HARRISON AVE, SUITE 500, BOSTON

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-28

Neueste SEC-Einreichungen

HLVX's Discussions on Twitter

Vergleichen Sie HLVX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HLVX Hillevax Inc	1.99	93.19M	0	-123.57M	-97.53M	-3.04
ONC Beone Medicines Ltd Adr	255.86	26.69B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	450.50	114.81B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.232	41.83M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	84.34	6.60B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	493.22	65.36B	14.09B	4.50B	2.96B	39.28

Hillevax Inc Stock (HLVX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-07-09	Herabstufung	H.C. Wainwright	Buy → Neutral
2024-07-09	Herabstufung	Leerink Partners	Outperform → Market Perform
2024-07-09	Herabstufung	Stifel	Buy → Hold
2024-07-08	Herabstufung	Guggenheim	Buy → Neutral
2024-07-08	Herabstufung	JP Morgan	Overweight → Neutral
2023-12-13	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Hillevax Inc Aktie (HLVX) Neueste Nachrichten

May 22, 2025

HilleVax, Inc. (NASDAQ:HLVX) is largely controlled by institutional shareholders who own 51% of the company - Yahoo Finance

May 22, 2025

May 20, 2025

HilleVax, Inc. (NASDAQ:HLVX) Given Average Rating of “Hold” by Brokerages - Defense World

May 20, 2025

May 16, 2025

What is HC Wainwright’s Forecast for HilleVax Q2 Earnings? - Defense World

May 16, 2025

May 15, 2025

Voya Investment Management LLC Has $127,000 Stock Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

May 15, 2025

Barclays PLC Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

May 15, 2025

May 10, 2025

HilleVax Reports Improved Financial Performance - TipRanks

May 10, 2025

May 08, 2025

HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress - Bluefield Daily Telegraph

May 08, 2025

May 02, 2025

JPMorgan Chase & Co. Acquires 193,124 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World

May 02, 2025

May 01, 2025

Geode Capital Management LLC Decreases Stock Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

May 01, 2025

Apr 30, 2025

Potential Price Increase for HilleVax Inc (HLVX) After Recent Insider Activity - knoxdaily.com

Apr 30, 2025

Apr 28, 2025

HilleVax, Inc. (NASDAQ:HLVX) Receives $3.00 Average PT from Analysts - Defense World

Apr 28, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Bought by Russell Investments Group Ltd. - Defense World

Apr 27, 2025

Bank of Montreal Can Acquires 11,459 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Apr 27, 2025

Apr 23, 2025

Is HilleVax Inc (HLVX) worth investing in despite its overvalued state? - uspostnews.com

Apr 23, 2025

Apr 08, 2025

ATTENTION HLVX SHAREHOLDERS: Investors who Lost Money on HilleVax, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire

Apr 08, 2025

Apr 03, 2025

HKVX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire

Apr 03, 2025

HilleVax, Inc. (NASDAQ:HLVX) Receives $3.00 Consensus Price Target from Brokerages - Defense World

Apr 03, 2025

Apr 01, 2025

HilleVax (NASDAQ:HLVX) Given Neutral Rating at HC Wainwright - Defense World

Apr 01, 2025

Mar 31, 2025

Cautious Hold Rating on HilleVax Amid Norovirus Vaccine Development Setbacks - TipRanks

Mar 31, 2025

Mar 30, 2025

HilleVax Reports 2024 Financial Results Amid Strategic Exploration - MSN

Mar 30, 2025

Mar 29, 2025

HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress - The Manila Times

Mar 29, 2025

Mar 28, 2025